Principal Financial Group Inc Day One Biopharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$13.56 - $17.46 $1,464 - $1,885	108 Added 0.6%	17,977 $296,000
Q4 2023 Feb 07, 2024	BUY	$9.68 - $15.37 $851 - $1,352	88 Added 0.49%	17,869 $260,000
Q3 2023 Nov 02, 2023	BUY	$11.22 - $14.86 $17,604 - $23,315	1,569 Added 9.68%	17,781 $218,000
Q2 2023 Aug 07, 2023	BUY	$11.74 - $14.47 $29,338 - $36,160	2,499 Added 18.22%	16,212 $193,000
Q1 2023 May 09, 2023	BUY	$12.75 - $23.41 $8,733 - $16,035	685 Added 5.26%	13,713 $183,000
Q4 2022 Feb 09, 2023	BUY	$18.77 - $22.0 $244,535 - $286,616	13,028 New	13,028 $280,000

167

71.7M

163K

183K

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $1.07B
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.